The device, which was tested in an investigator-initiated trial, works by pushing tumor cells through fluid-filled chambers and sorting them based on how well they adhere to the chamber walls. When ...

Resting brain stem cells hardly differ from normal astrocytes, which support the nerve cells in the brain. How can almost identical cells perform such different functions? The key lies in the ...

Resting brain stem cells hardly differ from normal astrocytes, which support the nerve cells in the brain. How can almost identical cells perform such different functions? The key lies in the ...

CDKN2A is one of the body’s most important natural defenses against cancer. Often called the “cell cycle brake,” this gene tells cells when to stop dividing and helps damaged cells self-destruct. In ...

Vector suppliers need better ways of growing adherent cells, according to the team behind a new single-use culturing platform, who say current technologies are not suited to industrial-scale ...

Global DNA-methylation is affected in G- cells. Global methylation level analysis in G− and G+ condition. (A) Bart chart representing the methylation level of individual sample (y-axis, 1 = 100%) in ...

Adherent cell assays have lagged behind in automation, slowing drug discovery. Semarion’s SemaCyte® microcarrier platform streamlines these workflows by making adherent cells assay-ready, improving ...

The race for early cancer detection is one that physicians have been running for millennia. In one of humanity’s oldest surviving medical texts, the ancient Egyptian physician Imhotep described 46 ...

New preclinical findings highlight Telomir-1’s ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene – often called the body’s natural “cell cycle brake.” These results ...